J. L. Culver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
J. L. Culver has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
B. A. Arnow
Stanford University, Department of Psychiatry and Behavioral Sciences
1 shared publicationT. A. Ketter
Stanford University, Department of Psychiatry and Behavioral Sciences
1 shared publication
Latest Publications
- 17 November 2006
- Published by Wiley in Journal of Clinical Psychology
- Vol. 63 (1) , 73-92
Bipolar disorder: Improving diagnosis and optimizing integrated care
Bipolar disorder is a chronic, severe condition commonly causing substantial mortality and psychosocial morbidity. Challenges in recognition can delay the institution of appropriate management, whereas misdiagnosis may initiate pharmacologic interventions that adversely affect the condition's course. Pharmacotherapy remains the foundation of treatment. In addition to efficacy, tolerability is an important consideration in medication choice, particularly for long‐term maintenance because of its impact on adherence. Mood stabilizers are the classic treatments for bipolar disorder. Newer agents such as atypical antipsychotics may offer efficacy and/or tolerability advantages compared with other medications. The role of antidepressants in bipolar disorder remains controversial. Growing evidence indicates that adjunctive psychosocial interventions improve long‐term functioning; consequently, psychologists are becoming increasingly involved in the long‐term care of patients with bipolar disorder. This review seeks to update psychologists and related healthcare professionals on recent advances and the current limitations in the diagnosis and treatment of bipolar disorder. © 2006 Wiley Periodicals, Inc. J Clin Psychol 63: 73–92, 2007.
- 17 November 2006
- Published by Wiley in Journal of Clinical Psychology
- Vol. 63 (1) , 73-92
Bipolar disorder: Improving diagnosis and optimizing integrated care
Bipolar disorder is a chronic, severe condition commonly causing substantial mortality and psychosocial morbidity. Challenges in recognition can delay the institution of appropriate management, whereas misdiagnosis may initiate pharmacologic interventions that adversely affect the condition's course. Pharmacotherapy remains the foundation of treatment. In addition to efficacy, tolerability is an important consideration in medication choice, particularly for long‐term maintenance because of its impact on adherence. Mood stabilizers are the classic treatments for bipolar disorder. Newer agents such as atypical antipsychotics may offer efficacy and/or tolerability advantages compared with other medications. The role of antidepressants in bipolar disorder remains controversial. Growing evidence indicates that adjunctive psychosocial interventions improve long‐term functioning; consequently, psychologists are becoming increasingly involved in the long‐term care of patients with bipolar disorder. This review seeks to update psychologists and related healthcare professionals on recent advances and the current limitations in the diagnosis and treatment of bipolar disorder. © 2006 Wiley Periodicals, Inc. J Clin Psychol 63: 73–92, 2007.